IP Library Granted Patent US 9,714,411
Granted Patent B2
US 9,714,411 · App. 14/954,705 · Granted Jul 25, 2017

Animal protein-free media for cultivation of cells

Inventors: Leopold Grillberger (Vienna, AT); Manfred Reiter (Vienna, AT); Wolfgang Mundt (Vienna, AT); Friedrich Dorner (Vienna, AT)
Assignees: Baxalta GmbH; Baxalta Incorporated
C12N5/0043C12N5/0682C12N2500/46C12N2500/74C12N2500/76C12N2500/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,714,411
App. No.
14/954,705
Granted
Jul 25, 2017
Kind
B2
Abstract

The present invention relates to animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate. The invention also relates to animal protein-free culturing processes, wherein cells can be cultivated, propagated and passaged without adding supplementary animal proteins in the culture medium. These processes are useful in cultivating cells, such as recombinant cells or cells infected with a virus, and for producing biological products by cell culture processes.

Claims (28)

1. An animal protein-free cell culture medium comprising putrescine and at least one protein hydrolysate, wherein the hydrolysate is derived from plants or yeast, and wherein the putrescine is present in the culture medium in a concentration ranging from about 0.5 to about 10 mg/L.

2. The animal protein-free cell culture medium of claim 1 , wherein the medium further comprises cadaverine, spermidine, spermine, agmatine, or ornithine; or a combination thereof.

3. The animal protein-free cell culture medium of claim 1 , wherein the protein hydrolysate is soy hydrolysate in a concentration ranging from about 0.05% (w/v) to about 5% (w/v).

4. The animal protein-free cell culture medium of claim 1 , wherein the polyamine originates from a source other than a protein hydrolysate.

5. The animal protein-free cell culture medium of claim 1 , wherein the polyamine is present in the culture medium in a concentration ranging from about 0.5 to 30 mg/L.

6. The animal protein-free cell culture medium of claim 1 , wherein the protein hydrolysate is present in the culture medium in a total concentration ranging from about 0.05% (w/v) to about 5% (w/v) for all protein hydrolysates.

7. The animal protein-free cell culture medium of claim 1 , wherein the protein hydrolysate is derived from a plant selected from the group consisting of cereals and soy.

8. A method of cultivating cells, comprising the steps of:

(a) providing an animal protein-free cell culture medium according to claim 1 , and

(b) propagating the cells in the medium to form a cell culture.

9. The method of claim 8 , wherein the cells are selected form the group consisting of mammalian cells, insect cells, avian cells, bacterial cells, and yeast cells.

10. The method of claim 8 , wherein the cells are cultivated by a method selected from the group consisting of batch-cultivation, feed-batch-cultivation, perfusion cultivation, and chemostat-cultivation.

11. A method for expressing a target protein, comprising the steps of:

(a) providing a culture of cells that have been grown in an animal protein-free cell culture medium of claim 1 ;

(b) introducing a nucleic acid sequence comprising a sequence coding for the target protein into the cells;

(c) selecting the cells carrying the nucleic acid sequence; and

(d) selectively inducing the expression of the target protein in the cells.

12. The method of claim 11 , wherein the cells are selected from the group consisting of mammalian cells, insect cells, avian cells, bacterial cells, and yeast cells.

13. The method of claim 1 , wherein the cell/target protein combination is selected form the group consisting of CHO cells/coagulation factor VIII, BHK cells/erythropoietin, Epstein Barr virus transformed, and immortalized human B cells/human antibodies.

14. The method of claim 11 , wherein the cells are cultivated by a method selected from the group consisting of batch-cultivation, feed-batch-cultivation, perfusion cultivation, and chemostat-cultivation.

15. A method for producing a virus, comprising the steps of:

a) providing a culture of cells that have been grown in an animal protein-free cell culture medium of claim 1 ;

(b) infecting the cells with the virus;

(c) selecting the virus-infected cells; and

(d) incubating the cells to propagate the virus.

16. The method of claim 15 , wherein the cells are selected from the group consisting of mammalian cells, insect cells, avian cells, bacterial cells, and yeast cells.

17. The method of claim 15 , wherein the cell/virus combination is selected from the group consisting of Vero cell/attenuated vaccinia virus, Vero cell/vaccinia virus, Vero cell/hepatitis A virus, Vero cell/influenza virus, Vero cell/West Nile virus, Vero cell/SARS virus, and chicken embryo cells/FSME virus.

18. The method of claim 15 , wherein the cells are cultivated by a method selected from the group consisting of batch-cultivation, feed-batch-cultivation, perfusion cultivation, and chemostat-cultivation.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0005 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2016
From: GRILLBERGER, LEOPOLD; REITER, MANFRED; MUNDT, WOLFGANG; DORNER, FRIEDRICH
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 039473/0545 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2016
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 039725/0383 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2016
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 039726/0001 →
Continuity (6)
Continuation 14268859 · May 2, 2014
Continuation 13864118 · Apr 16, 2013
Continuation 12965111 · Dec 10, 2010
Continuation 11858844 · Sep 20, 2007
Division 10976399 · Oct 29, 2004
Related Publication 20160083689A1 · Mar 24, 2016